Medroxyprogesterone is widely used in hormone replacement therapy (HRT) to manage symptoms of menopause, such as hot flashes and vaginal dryness. It is often combined with estrogen to protect the uterus from the potential risks of estrogen therapy, such as endometrial hyperplasia. Additionally, it is prescribed as a contraceptive, available in both oral and injectable forms, to prevent pregnancy by inhibiting ovulation and altering the cervical mucus and endometrium. It is also utilized in the treatment of abnormal uterine bleeding, endometriosis, and certain types of cancer, such as endometrial and renal cancers. In some cases, it is used to induce menstrual cycles in women with amenorrhea. Its versatility in addressing hormonal imbalances and reproductive health issues makes it a key medication in gynecology and endocrinology.